X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8469) 8469
science & technology (6318) 6318
life sciences & biomedicine (5588) 5588
colonic neoplasms - immunology (4257) 4257
animals (3964) 3964
female (3877) 3877
colonic neoplasms - pathology (3568) 3568
male (3316) 3316
mice (2897) 2897
oncology (2691) 2691
middle aged (2176) 2176
colon cancer (2138) 2138
aged (1952) 1952
colorectal cancer (1793) 1793
colonic neoplasms - metabolism (1694) 1694
cancer (1664) 1664
adult (1458) 1458
cell line, tumor (1386) 1386
colonic neoplasms - genetics (1360) 1360
colon (1114) 1114
tumors (1103) 1103
colonic neoplasms - drug therapy (1078) 1078
abridged index medicus (1063) 1063
gastroenterology & hepatology (1052) 1052
tumor cells, cultured (1050) 1050
mice, inbred balb c (1049) 1049
immunology (1036) 1036
adenocarcinoma - immunology (1033) 1033
colonic neoplasms - therapy (1007) 1007
surgery (923) 923
research article (911) 911
rectal neoplasms - immunology (804) 804
research (769) 769
cell biology (765) 765
analysis (744) 744
colonic neoplasms - surgery (733) 733
science & technology - other topics (733) 733
mice, nude (728) 728
immunohistochemistry (725) 725
adenocarcinoma - pathology (721) 721
neoplasm transplantation (715) 715
aged, 80 and over (708) 708
multidisciplinary sciences (707) 707
medicine & public health (700) 700
medicine (687) 687
apoptosis (661) 661
carcinoembryonic antigen - analysis (658) 658
prognosis (618) 618
biochemistry & molecular biology (600) 600
cell line (592) 592
gene expression (582) 582
gastroenterology (576) 576
science (576) 576
colonic neoplasms - diagnosis (573) 573
mice, inbred c57bl (569) 569
rats (558) 558
metastasis (547) 547
antigens, neoplasm - immunology (510) 510
neoplasm staging (503) 503
antibodies, monoclonal - immunology (495) 495
pathology (494) 494
health aspects (491) 491
proteins (491) 491
immunotherapy (483) 483
carcinoembryonic antigen - immunology (476) 476
antigens, neoplasm - analysis (457) 457
disease models, animal (456) 456
care and treatment (450) 450
risk factors (449) 449
hepatology (447) 447
medicine, research & experimental (447) 447
research & experimental medicine (447) 447
neoplasm metastasis (445) 445
antibodies, monoclonal (444) 444
gene expression regulation, neoplastic (443) 443
signal transduction (426) 426
colonic neoplasms (420) 420
cell proliferation (417) 417
time factors (410) 410
internal medicine (407) 407
genetic aspects (396) 396
flow cytometry (391) 391
breast neoplasms - immunology (358) 358
colonic neoplasms - prevention & control (355) 355
liver neoplasms - secondary (353) 353
immunoenzyme techniques (352) 352
mutation (351) 351
t-lymphocytes - immunology (348) 348
transplantation, heterologous (345) 345
neoplasms - immunology (344) 344
colonoscopy (336) 336
chemotherapy (334) 334
colorectal carcinoma (332) 332
treatment outcome (325) 325
colonic neoplasms - mortality (324) 324
inflammation (324) 324
rodents (324) 324
apoptosis - drug effects (322) 322
colon - pathology (322) 322
development and progression (321) 321
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9562) 9562
Japanese (175) 175
German (80) 80
French (77) 77
Chinese (65) 65
Russian (39) 39
Italian (32) 32
Polish (19) 19
Spanish (19) 19
Hungarian (7) 7
Norwegian (7) 7
Danish (6) 6
Czech (4) 4
Portuguese (4) 4
Swedish (4) 4
Romanian (2) 2
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, pp. e0179501 - e0179501
Innovative therapies for solid tumors are urgently needed. Recently, therapies that harness the host immune system to fight cancer cells have successfully... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Colonic Neoplasms - genetics | DNA Methylation - immunology | DNA, Neoplasm - metabolism | Humans | Antigens, Neoplasm - biosynthesis | Ovarian Neoplasms - pathology | Male | Colonic Neoplasms - metabolism | Testicular Neoplasms - pathology | Ovarian Neoplasms - genetics | Colonic Neoplasms - immunology | Female | Ovarian Neoplasms - metabolism | Caco-2 Cells | Antigens, Neoplasm - genetics | Testicular Neoplasms - genetics | Antigens, Neoplasm - immunology | Testicular Neoplasms - metabolism | Antigen Presentation - genetics | DNA Methylation - genetics | Testicular Neoplasms - immunology | Animals | Colonic Neoplasms - pathology | DNA, Neoplasm - immunology | Mice | DNA, Neoplasm - genetics | Ovarian Neoplasms - immunology | Colon cancer | Tumor antigens | Physiological aspects | Development and progression | Genetic aspects | Research | Methylation | Ovarian cancer | Therapy | Biotechnology | Animal models | Ovarian carcinoma | Medical innovations | CD58 antigen | Antigen processing | Genomes | Tissues | Cancer therapies | Immunotherapy | Surgery | Cell cycle | DNA methylation | Inhibition | Colon | Drug dosages | Deoxyribonucleic acid--DNA | Immune system | Antigen presentation | Antigens | Tumor cells | Melanoma | Tumor cell lines | Gene expression | Ribonucleic acid--RNA | Patients | Medicine | Inhibitors | Epigenetics | Solid tumors | Tumors | Cancer | Index Medicus | RNA | Deoxyribonucleic acid | Ribonucleic acid | DNA
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 676 - 681
Abstract We wanted to determine whether allogeneic hematopoietic stem cell transplantation (HSCT) may result in long-term survival in patients with solid... 
Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Allogeneic hematopoietic stem cell transplantation | Colon carcinoma | Renal carcinoma | Cholangiocarcinoma | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Adenocarcinoma - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Kidney Neoplasms - immunology | Male | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Bile Duct Neoplasms - immunology | Neoplasm Metastasis | Graft vs Host Disease - mortality | Colonic Neoplasms - immunology | Adult | Female | Pancreatic Neoplasms - mortality | Transplantation Conditioning - methods | Graft vs Host Disease - diagnosis | Kidney Neoplasms - therapy | Colonic Neoplasms - therapy | Prostatic Neoplasms - pathology | Colonic Neoplasms - mortality | Adenocarcinoma - immunology | Pancreatic Neoplasms - pathology | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Kidney Neoplasms - mortality | Myeloablative Agonists | Prostatic Neoplasms - mortality | Graft vs Host Disease - pathology | Bile Duct Neoplasms - therapy | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Bile Duct Neoplasms - mortality | Colonic Neoplasms - pathology | Pancreatic Neoplasms - immunology | Survival Analysis | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Aged | Bile Duct Neoplasms - pathology | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Liver cancer | Colon cancer | Pancreatic cancer | Liver | Mortality | Stem cells | Metastasis | Health aspects | Prostate cancer | Risk factors | Hematopoietic stem cells | College teachers | Index Medicus
Journal Article
Nature medicine, ISSN 1546-170X, 12/2006, Volume 13, Issue 1, pp. 54 - 61
Anthracyclin-treated tumor cells are particularly effective in eliciting an anticancer immune response, whereas other DNA-damaging agents such as etoposide and... 
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Apoptosis - drug effects | Colonic Neoplasms - drug therapy | Dendritic Cells - immunology | Electrophoresis, Gel, Two-Dimensional | Immunoblotting | Antineoplastic Agents - therapeutic use | Protein Transport - drug effects | Calreticulin - genetics | Colonic Neoplasms - metabolism | Cell Cycle Proteins - antagonists & inhibitors | RNA Interference | Anthracyclines - pharmacology | Neoplasms, Experimental - immunology | Calreticulin - metabolism | Antigens, Differentiation - metabolism | Antineoplastic Agents - pharmacology | Cell Membrane - metabolism | Protein Phosphatase 1 | Cell Membrane - drug effects | Mitomycin - therapeutic use | Cell Cycle Proteins - metabolism | Phagocytosis - immunology | Etoposide - pharmacology | Etoposide - therapeutic use | Recombinant Proteins - pharmacology | Mitomycin - pharmacology | Animals | Apoptosis - immunology | Mice, Nude | Colonic Neoplasms - pathology | Cell Line, Tumor | Cell Membrane - immunology | Mice | Mice, Inbred BALB C | Anthracyclines - therapeutic use | Calreticulin - immunology | Neoplasms, Experimental - metabolism | Neoplasms, Experimental - drug therapy | Chemotherapy | Immunology | DNA damage | Rodents | Cancer | Apoptosis | Tumors | Index Medicus | Antigens, Differentiation | Cell Membrane | Anthracyclines | Dendritic Cells | Recombinant Proteins | Life Sciences | Calreticulin | Neoplasms, Experimental | Mitomycin | Etoposide | Antineoplastic Agents | Protein Transport | Phagocytosis | Cell Cycle Proteins | Colonic Neoplasms
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2010, Volume 138, Issue 6, pp. 2101 - 2114.e5
The connection between inflammation and tumorigenesis is well-established and in the last decade has received a great deal of supporting evidence from genetic,... 
Gastroenterology and Hepatology | Inflammation | Cytokines | Immunity | Colon Cancer | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Colonic Neoplasms - genetics | Colonic Neoplasms - prevention & control | Colonic Neoplasms - drug therapy | Colorectal Neoplasms - genetics | Humans | Inflammatory Bowel Diseases - immunology | Gene Expression Regulation, Neoplastic | Colon - immunology | Cell Transformation, Neoplastic - genetics | Colonic Neoplasms - immunology | Colorectal Neoplasms - drug therapy | Inflammation Mediators - metabolism | Inflammatory Bowel Diseases - genetics | Anti-Inflammatory Agents - therapeutic use | Inflammatory Bowel Diseases - complications | Anticarcinogenic Agents - therapeutic use | Inflammatory Bowel Diseases - drug therapy | Genetic Predisposition to Disease | Cytokines - metabolism | Risk Assessment | Signal Transduction | Neoplasm Invasiveness | Risk Factors | Colorectal Neoplasms - prevention & control | Colonic Neoplasms - secondary | Cell Transformation, Neoplastic - immunology | Animals | Colorectal Neoplasms - immunology | Colorectal Neoplasms - secondary | Colon - microbiology | Dendritic cells | Measles-mumps-rubella vaccine | Biological response modifiers | Sulfates | Risk factors | Dextran | Prostaglandins | Colon cancer | Gastrointestinal diseases | Vascular endothelial growth factor | Growth factors | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Molecular therapy, ISSN 1525-0016, 01/2014, Volume 22, Issue 1, pp. 18 - 27
Journal Article
PloS one, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, pp. e57911 - e57911
Background: Immune evasion is one of the recognized hallmarks of cancer. Inflammatory responses to cancer can also contribute directly to oncogenesis. Since... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Cell Adhesion Molecules - genetics | Colonic Neoplasms - genetics | Prognosis | Carcinoma, Squamous Cell - genetics | Humans | Gene Expression Regulation, Neoplastic | Databases, Genetic | Data Mining | Gene Expression Profiling | Inflammation - complications | Neoplasms - complications | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Neoplasms - genetics | Colonic Neoplasms - immunology | Adenocarcinoma - genetics | Colonic Neoplasms - mortality | Gene Expression | Adenocarcinoma - immunology | Neoplasms - mortality | Workflow | Inflammation - immunology | Carcinoma, Squamous Cell - immunology | Adenocarcinoma - complications | Colonic Neoplasms - complications | Head and Neck Neoplasms - immunology | Neoplasms - immunology | Carcinoma, Squamous Cell - complications | alpha Karyopherins - genetics | Inflammation - genetics | Head and Neck Neoplasms - complications | Head and Neck Neoplasms - genetics | Biomarkers, Tumor - genetics | Head and Neck Neoplasms - mortality | Neoplasm Staging | Adenocarcinoma - mortality | Cluster Analysis | Proteins | Immunohistochemistry | DNA microarrays | Analysis | Genes | Cancer | Ovarian cancer | Transcription factors | Ovarian carcinoma | Leukemia | Lung cancer | CXCL13 protein | Biochemistry | Genomes | Tissue analysis | Metastasis | Datasets | Liver cancer | Angiogenesis | Immunology | Colon cancer | Tumorigenesis | Colon | Neck | Protein transport | Pancreas | Bioinformatics | Immune system | Immunoglobulins | Head | Cytokines | Data processing | Inflammation | Breast cancer | CD36 antigen | Gene expression | Low level | Nuclear transport | Liquid oxygen | Biomarkers | Hypoxia | Molecular biology | Prostate | Prostate cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 35, pp. 8968 - 8977
Journal Article